0AF Stock Overview
Engages in the research and development of patented optical sensor technology for the development of smart wound care dressings in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Odinwell AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.24 |
| 52 Week High | SEK 0.27 |
| 52 Week Low | SEK 0.029 |
| Beta | 0.063 |
| 11 Month Change | 90.32% |
| 3 Month Change | 461.90% |
| 1 Year Change | 227.78% |
| 33 Year Change | -27.61% |
| 5 Year Change | n/a |
| Change since IPO | -59.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0AF | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 6.3% | -1.0% | -0.02% |
| 1Y | 227.8% | -7.3% | 8.2% |
Return vs Industry: 0AF exceeded the German Medical Equipment industry which returned -7.3% over the past year.
Return vs Market: 0AF exceeded the German Market which returned 8.2% over the past year.
Price Volatility
| 0AF volatility | |
|---|---|
| 0AF Average Weekly Movement | 28.0% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 0AF's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 0AF's weekly volatility has increased from 22% to 28% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 3 | Marcus Andersson | odinwell.com |
Odinwell AB engages in the research and development of patented optical sensor technology for the development of smart wound care dressings in Sweden. It develops smart wound care for bandages and plasters. Odinwell AB was incorporated in 2019 and is based in Halmstad, Sweden.
Odinwell AB Fundamentals Summary
| 0AF fundamental statistics | |
|---|---|
| Market cap | €5.80m |
| Earnings (TTM) | -€474.15k |
| Revenue (TTM) | €408.78k |
14.2x
P/S Ratio-12.2x
P/E RatioIs 0AF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0AF income statement (TTM) | |
|---|---|
| Revenue | SEK 4.70m |
| Cost of Revenue | SEK 2.11k |
| Gross Profit | SEK 4.70m |
| Other Expenses | SEK 10.15m |
| Earnings | -SEK 5.45m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 99.96% |
| Net Profit Margin | -115.99% |
| Debt/Equity Ratio | 0% |
How did 0AF perform over the long term?
See historical performance and comparison